The U.S Food and Drugs Administration(FDA), in a safety announcement has warned against the potential side effects of a class of commonly-prescribed powerful antibiotic, including the drug known by the brand Ciprox which is marketed in Ngeria under the generic name Ciprofloxacin.

The FDA also announced that the potential side effects of Fluoroquindone, another anti-bacterial drug often over weigh their benefit.

 

No Comments

Leave a Comment